Main Logo

PSMA Imaging: Place in Prostate Cancer Landscape and Trials Outpacing Clinical Practice

By Joelle Hamilton, MD, Yu-Wei Chen, MD, MS, Katy Beckermann, MD, PhD, Kerry Schaffer, MD - Last Updated: October 18, 2024

In this roundtable, a panel consisting of Joelle Hamilton, MD, Urology Centers of Alabama; Katy Beckermann, MD, PhD, Vanderbilt University Medical Center; Yu-Wei Chen, MD, University of California, San Diego; and Kerry Schaffer, MD, Vanderbilt University Medical Center, share their expertise on PSMA-directed therapies and the changing landscape of advanced prostate cancer treatment. Topics include the latest in theranostics, radioligand therapy, and the impact of PSMA imaging. They also discuss highlights from recent clinical trials and real-world experiences, as well as how multidisciplinary teams are shaping the future of prostate cancer care.

Watch part two of this roundtable series: Pushing the Treatment Landscape Forward: Real-World Radioligand Therapy Assessment and Management

Post Tags:Roundtable RLT